Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy

Determination of the risk–benefit ratio associated with the use of novel coronavirus disease 2019 (COVID-19) repurposed drugs in older adults with polypharmacy is mandatory. Our objective was to develop and validate a strategy to assess risk for adverse drug events (ADE) associated with COVID-19 rep...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Med
Hlavní autoři: Al Rihani, Sweilem B., Smith, Matt K., Bikmetov, Ravil, Deodhar, Malavika, Dow, Pamela, Turgeon, Jacques, Michaud, Veronique
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7463624/
https://ncbi.nlm.nih.gov/pubmed/32785135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9082591
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky